Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…
In testimony before Congress Thursday, Johnson & Johnson’s CEO apologized for the problems that have beset his company, including the quality issues with its children’s medicines and the “phantom recall” of a batch of Motrin. …
CEO William Weldon will apologize to Congress for a series of product recalls over the past year. The company is also expected to resume shipments of children’s cold medication next week.
Continue reading J&…
U.S. hospitals are doing a more effective job treating patients for heart attacks, pneumonia and surgical procedures, an independent healthcare accreditation organization said in a report released today.
Contin…